The Effect of Antiepileptic Drugs on 5‐HT1A–Receptor Binding Measured by Positron Emission Tomography
- 6 March 2006
- Vol. 47 (3) , 499-503
- https://doi.org/10.1111/j.1528-1167.2006.00458.x
Abstract
To study the effect of antiepileptic drugs (AEDs) on 5-HT(1A)-receptor binding in patients with temporal lobe epilepsy. 5-HT(1A)-receptor binding, measured by positron emission tomography, is reduced in patients with temporal lobe epilepsy. Antiepileptic drugs may act on the serotonergic system, as shown in animal models, and thus affect receptor-binding measurements. We analyzed the effect of AEDs on 5-HT(1A)-receptor binding in 31 patients and 10 normal controls. Patients with structural lesions, progressive neurologic disorders, or taking other medications were excluded. None had a seizure for >or=2 days before positron emission tomography (PET). [(18)F]FCWAY PET was performed on a GE Advance scanner with continuous EEG monitoring. Functional images of the distribution volume (V) were generated. Anatomic regions of interest were applied to co-registered PET images, after correction for partial-volume effect. Patients had significantly higher [(18)F]FCWAY free fraction (f(1)) than did controls. No AED effects were observed on interictal [(18)F]FCWAY binding after correction for plasma free fraction. [(18)F]FCWAY V/f1 reduction in epileptic foci was not affected by AEDs. 5-HT(1A)-receptor binding is reduced in temporal lobe epileptic foci after partial-volume correction. AED plasma free fractions should be measured when PET receptor studies are performed in patients with epilepsy.Keywords
This publication has 26 references indexed in Scilit:
- Differential effects of paroxetine on raphe and cortical 5-HT1A binding: A PET study in monkeysNeuroImage, 2005
- Quantitative in Vivo Microdialysis Study on the Influence of Multidrug Transporters on the Blood-Brain Barrier Passage of Oxcarbazepine: Concomitant Use of Hippocampal Monoamines as Pharmacodynamic Markers for the Anticonvulsant ActivityThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Regional Heterogeneity of 5-HT1A Receptors in Human Cerebellum as Assessed by Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 2005
- Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEGNeuroImage, 2004
- 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET studyBrain, 2004
- Is there a role for 5-HT1A agonists in the treatment of depression?Biological Psychiatry, 2003
- Brain Uptake of the Acid Metabolites of F-18???Labeled WAY 100635 AnalogsJournal of Cerebral Blood Flow & Metabolism, 2003
- The Suitability of [11C]-α-Methyl-L-tryptophan as a Tracer for Serotonin Synthesis: Studies With Dual Administration of [11C] and [14C] Labeled TracerJournal of Cerebral Blood Flow & Metabolism, 2000
- Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR)Life Sciences, 1995
- A quantitative model for the in vivo assessment of drug binding sites with positron emission tomographyAnnals of Neurology, 1984